Abstract

BackgroundDiabetic peripheral neuropathy (DPN) is a chronic sensorimotor length-dependent and symmetrical polyneuropathy. Some peripheral neuropathies have painful presentations, and some are painless. DPN can have a potential impact on the patient's life.ObjectivesThis study was conducted in order to investigate the frequency of neuropathic sensory symptoms among patients with uncontrolled diabetes mellitus.MethodsThis is a cross-sectional study conducted in the Security Forces hospital using the Neuropathy Total Symptom Score-6 (NTSS-6) questionnaire. The questionnaire was administered by contacting patients through the phone. Patients with uncontrolled diabetes (HbA1C >9) were included in the study.ResultsThis study included 285 participants; 58.9% had type II diabetes and 41.1% had type I diabetes, 156 (54.7%) were females, and 129 (45.3%) were males. Most of the patients (51.1%) were 45-64 years old and the majority were non-smokers (77.9%). Patients with neuropathic pain were 182 (63.9%); 79 (43.4%) of them were males and 103 (56.6%) were females. The prevalence of neuropathic symptoms was much higher in females than in males.ConclusionThe prevalence of painful DPN is high among patients with long-term uncontrolled diabetes mellitus. Older, unemployed, and low-educated patients are at higher risk of developing painful DPN. Proper glycemic control and lifestyle modifications are essential in preventing the progression of this condition.

Highlights

  • Diabetes mellitus (DM) is one of the largest worldwide epidemics in developing and developed countries and one of the most important public health challenges [1]

  • This is a cross-sectional study conducted in the Security Forces hospital using the Neuropathy Total Symptom Score-6 (NTSS-6) questionnaire

  • The prevalence of neuropathic symptoms was much higher in females than in males

Read more

Summary

Introduction

Diabetes mellitus (DM) is one of the largest worldwide epidemics in developing and developed countries and one of the most important public health challenges [1]. In 2019, the global prevalence of DM is estimated to be 463 million (9.3%) [2]. An increase in DM's prevalence is expected and estimated to be 578 million (10.2%) and 700 million (10.9%) in 2030 and 2045 consecutively [2]. Increased prevalence of DM is associated with increased diabetic complications which significantly affect patients' quality of life [3]. Diabetic peripheral neuropathy (DPN) is typically defined as a chronic sensorimotor length-dependent and symmetrical polyneuropathy [4]. DPN have several pathways; some of them have painful presentations, and the others are painless [5]. Diabetic peripheral neuropathy (DPN) is a chronic sensorimotor length-dependent and symmetrical polyneuropathy. Some peripheral neuropathies have painful presentations, and some are painless. DPN can have a potential impact on the patient's life

Objectives
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call